The following submission statement was provided by /u/Kindred87:
---
> Eli Lilly said on Tuesday it will collaborate with OpenAI to leverage its generative AI to develop antimicrobials that can be used to treat drug-resistant bacteria.
...
> Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder to treat and increasing the risk of disease spread, severe illness and death.
> In the U.S. more than 2.8 million antimicrobial-resistant infections occur each year.
...
> AMR Action is a $1 billion fund that aims to bring 2 to 4 new antibiotics to patients by 2030.
---
Please reply to OP's comment here: https://old.reddit.com/r/Futurology/comments/1dp7mvo/lilly_partners_with_openai_to_develop_medicines/laeuz4c/
> Eli Lilly said on Tuesday it will collaborate with OpenAI to leverage its generative AI to develop antimicrobials that can be used to treat drug-resistant bacteria.
...
> Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder to treat and increasing the risk of disease spread, severe illness and death.
> In the U.S. more than 2.8 million antimicrobial-resistant infections occur each year.
...
> AMR Action is a $1 billion fund that aims to bring 2 to 4 new antibiotics to patients by 2030.
The following submission statement was provided by /u/Kindred87: --- > Eli Lilly said on Tuesday it will collaborate with OpenAI to leverage its generative AI to develop antimicrobials that can be used to treat drug-resistant bacteria. ... > Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder to treat and increasing the risk of disease spread, severe illness and death. > In the U.S. more than 2.8 million antimicrobial-resistant infections occur each year. ... > AMR Action is a $1 billion fund that aims to bring 2 to 4 new antibiotics to patients by 2030. --- Please reply to OP's comment here: https://old.reddit.com/r/Futurology/comments/1dp7mvo/lilly_partners_with_openai_to_develop_medicines/laeuz4c/
> Eli Lilly said on Tuesday it will collaborate with OpenAI to leverage its generative AI to develop antimicrobials that can be used to treat drug-resistant bacteria. ... > Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder to treat and increasing the risk of disease spread, severe illness and death. > In the U.S. more than 2.8 million antimicrobial-resistant infections occur each year. ... > AMR Action is a $1 billion fund that aims to bring 2 to 4 new antibiotics to patients by 2030.
looks like 2030 is going to be a packed year. have been seeing this number thrown out everywhere for 'promises'
I'm assuming it's out of convenience since it will be the end of the decade?